Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

How relationships and migration shape HIV prevention among African immigrants

Tests a relationship-focused HIV prevention component in African immigrants living in New York and Massachusetts.

Plain-language title generated from the registry record
Registry title: Examining Migration, Social Bonds, Transnationalism, and HIV Prevention Pathways Among African Immigrants.

Key facts

Where
Buffalo, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

Source: NCT07565584, who can take part

Where in United States

  • State University of New York at BuffaloBuffalo, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
State University of New York at Buffalo
Trial code
NCT07565584
Record updated
16 October 2026
Original description
The goal of this mixed-methods pilot study is to learn whether migration experiences, social bonds, and transnational ties shape HIV prevention decision-making, including HIV testing, HIV self-testing (HIVST), and pre-exposure prophylaxis (PrEP) uptake, among first-generation African immigrants aged 18 to 50 residing in New York and Massachusetts. The main questions it aims to answer are:Read full original descriptionShow less

Migration, Social Bonds, Transnationalism, and HIV Prevention Pathways Among African Immigrants (MiST-Pathways)

The goal of this mixed-methods pilot study is to learn whether migration experiences, social bonds, and transnational ties shape HIV prevention decision-making, including HIV testing, HIV self-testing (HIVST), and pre-exposure prophylaxis (PrEP) uptake, among first-generation African immigrants aged 18 to 50 residing in New York and Massachusetts. The main questions it aims to answer are:

* What relationship typologies and migration-related relational mechanisms influence HIV testing, HIVST, and PrEP decision-making among African immigrants? * Can a relationship-tailored HIV prevention intervention component, co-developed with the community, demonstrate feasibility and acceptability among African immigrants? * Does exposure to the prioritized intervention component show directional increases in HIV testing intention, willingness to use HIVST, interest in PrEP, and readiness for relationship-based prevention communication? There is no comparison group. All Aim 3 participants receive the same co-developed intervention component.

Participants will:

* Complete a qualitative interview (60-90 minutes) and/or a structured electronic survey (15-20 minutes) about their relationship experiences, migration history, and HIV prevention behaviors. * Take part in a 3-4 hour structured group deliberation session called a Palava Hut Conversation to co-develop and prioritize HIV prevention intervention ideas. * Complete a baseline survey, receive the prioritized intervention component in a structured Zoom session, and complete a follow-up survey with an optional 60-90 minute cognitive interview for a subset of participants.

Inclusion: Age 18 to 50 years at the time of enrollment; Self-identify as a first-generation African immigrant (born in an African country and currently residing in the United States); Currently reside in New York or Massachusetts; Able to communicate in English at approximately a 3rd-grade reading level; Have access to a smartphone or computer with internet capability sufficient to participate in Zoom and/or WhatsApp-based study activities; Willing and able to provide informed consent.

Exclusion: Are under 18 years of age; Do not self-identify as a first-generation African immigrant; Do not reside in New York or Massachusetts; Are unable to provide informed consent; Do not have access to the technology required for virtual participation (Zoom and/or WhatsApp).

ClinicalTrials.gov NCT07565584